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ABSTRACT
￿
Yeast cells secrete a variety of glycosylated proteins. At least two of these proteins,
invertase and acid phosphatase, fail to be secreted in a new class of mutants that are
temperature-sensitive for growth . Unlike the yeast secretory mutants previously described
(class A sec mutants; Novick, P., C. Field, and R. Schekman, 1980, Cell., 21 :205-420), class B
sec mutants (sec53, sec59) fail to produce active secretory enzymes at the restrictive temper-
ature (37°C). sec53 and sec59 appear to be defective in reactions associated with the
endoplasmic reticulum. Although protein synthesis continues at a nearly normal rate for 2 h
at 37°C, incorporation of [3 H]mannose into glycoprotein is reduced . Immunoreactive poly-
peptide forms of invertase accumulate within the cell which have mobilities on SDS PAGE
consistent with incomplete glycosylation : sec53 produces little or no glycosylated invertase,
and sec59 accumulates forms containing 0-3 of the 9-10 N-linked oligosaccharide chains that
are normally added to the protein . In addition to secreted enzymes, maturation of the vacuolar
glycoprotein carboxypeptidase Y, incorporation of the plasma membrane sulfate permease
activity, and secretion of the major cell wall proteins are blocked at 37°C.
Studies on the secretory process in both procaryotic and
eucaryotic cells have focused on the events associated with
synthesis and processing of secretory proteins. A number of
proposals have been made that seek to explain how proteins
pass into or through membranes (1-4). Two ofthese theories,
the signal hypothesis (1) and the membrane trigger hypothesis
(2), have different experimental predictions. The signal hy-
pothesis, which was first proposed for secretory proteins and
later extended to membrane proteins (5), postulates that an
amino terminal signal directs the nascent secretory protein to
a site on the endoplasmic reticulum (ER).' The signal peptide
is cleaved as the secretory protein penetrates into the lumen
of the ER. The membrane trigger hypothesis, on the other
hand, proposes that the signal sequence allows a precursor to
assume a conformation compatible with membrane penetra-
tion. According to this view, no membrane proteins are
The following two papers are dedicated to Dr. Arthur Kornberg on
his 65th birthday.
'Abbreviations used in this paper:
￿
ConA, concanavalin A; CPY,
carboxypeptidase Y; endo H, endoglycosidase H; SRP, signal recog-
nition particle; TNBS, trinitrobenzenesulfonic acid; TNP, trinitro-
phenol; YP medium, yeast extract-peptone.
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needed to facilitate translocation of newly synthesized mem-
brane or secretory proteins. Thus, a fundamental distinction
between the two proposals is the requirement for a translo-
cation system.
Recently, a ribonucleoprotein complex (signal recognition
particle, SRP) has been shown to bind to polysomes engaged
in secretory protein synthesis causing an arrest in translation
(6, 7). A 72-kdalton ER protein (the docking protein or the
SRP receptor) releases the translation block (8, 9). It has been
proposed that the SRP binds to the signal sequence portion
of a nascent secretory polypeptide and directs the translation
complex to the docking protein on the ER. The SRP and
docking protein fulfill functions required at an early step in
protein translocation; latersteps may require additional func-
tions. Conditional lethal mutants that affect protein translo-
cation could reveal new steps in the penetration process.
Earlier reports from this laboratory have described the
isolation and characterization of yeast mutants that are tem-
perature-sensitive for growth and secretion (10, 11). These
mutants (class A sec mutants) fail to secrete invertase and
acid phosphatase at the restrictive temperature (37°C), and
instead accumulate active enzymes within membrane-en-
35closed organelles. The class A sec mutants are able to trans-
locate proteins across the ER but these are blocked at various
stages oftransport to the cell surface.
Glycoproteins acquire N-glycosidically linked oligosaccha-
rides during transit across the ER membrane (12). The trans-
fer of oligosaccharide to protein should be blocked indirectly
if polypeptide transit into the ER is disrupted. Mutants that
block this transit step should synthesize secretory proteins
that contain little or no carbohydrate. Under these conditions
certain unglycosylated secretory proteins will not fold into
active enzymes. In particular, yeast invertase and acid phos-
phatase, both of which normally contain about 50% carbo-
hydrate, are not produced in an active form when oligosac-
charide synthesis is blocked by treatment of cells with tuni-
camycin (13, 14). In this report we describe a new class of
yeast secretory mutants which appear to affect the transit of
secretory, vacuolar, and plasma membrane polypeptides into
the ER.
MATERIALS AND METHODS
Strains, Growth Conditions, Reagents, and Buffers: Sac-
charomyces cerevisiae haploid strain X2180-IA (a, ga12) was obtained from
the Yeast Genetics Stock Center (Berkeley, California). BR231-8B (SUCO) was
obtainedfrom S. Fogel (UniversityofCalifornia, Berkeley).pep4-3 was obtained
from E. W. Jones (Carnegie Mellon University). pRB58 is a 2 Win plasmid
containing the SUC2 gene (15). All sec mutant strains were derived from
X2180-1A. Standard genetic techniques were used to construct SF402-4D,
SF649-2A/pRB58, SF629-3C/pRB58, and SF610-7B/pRB58. HMSF331
(sec53-6) and HMSF375 (sec53-I1) are original isolates. Standard genetic
techniques were used to construct haploid double sec mutant strains. Double
mutants were evaluated by genetic complementation with both parent strains
to ensure retention ofboth mutant alleles.
YPD medium (yeast extract-peptone-dextrose) contained l% Bacto-Yeast
extract, 2% Bacto-Peptone and 2% glucose; YP medium was the same with
different levels of glucose. Wickerham's minimal medium (16) was used with
different levels ofglucose; for sulfate-free medium, chloride salts replaced all
sulfate salts; for labeling with ['H]mannose, minimal medium was supple-
mented with 0.5% casamino acids, 1.8% galactose, and 0.2% glucose. For
strains harboring the pRB58 plasmid, minimal medium was supplemented
with histidine (20 Ag/ml) and lysine (20 Ag/ml). Phosphate-depleted YPD was
prepared as described by Rubin (17). To change growth medium, cells were
sedimented in a clinical centrifuge and resuspended in new medium. The
absorbance of cell suspensions was measured in a 1-cm quartz cuvette at 600
nm in a Zeiss PMQ II spectrophotometer; 1 ODNO U corresponds to .15 mg
dry wt.
Other reagents were obtained as indicated: glucose oxidase, o-dianisidine,
peroxidase, p-nitrophenylphosphate, cycloheximide, phenylmethylsulfonyl flu-
oride, tosyllysine chloromethyl ketone, tunicamycin, trinitrobenzene sulfonic
acid, and concanavalin A (ConA)-Sepharose 4B (8 mg protein/ml gel) were
from Sigma] Chemical Co. (St. Louis, MO); H2'SSO4 was from ICN K & K
Laboratories, (Plainview, NY)andAmersham (Arlington Heights, IL); Enhance
and D-[ 1'H]mannose (13.2 Ci/mmole) were from New England Nuclear
(Boston, MA); IgG Sorb (fixed Staphylococcus aureus Cowan I cells) was from
the Enzyme Center (Boston, MA); glutaraldehyde, osmium tetroxide, and spurn
embedding medium were from Polysciences, Inc. (Warrington, PA); endogly-
cosidase H (endo H) was generously provided by P. Robbins (Massachusetts
Institute ofTechnology). ConA-Sepharosewaswashed fourtimes with an equal
volume of0.5 M NaCl, 0.5 M a-methyl-D-mannoside, then twice with reaction
buffer (described below), and resuspended in an equal volume of the same
buffer. Lyticase is a yeast lytic enzyme preparation useful in spheroplast
formation (18). Fraction II (30,000 U/mg; I U will lyse 0.2 OD6W U of
logarithmic phase cells in 30 min at 30°C) was used. Affinity-purified anti-
carboxypeptidase Y IgG, providedbyT. Stevens (thislaboratory), was prepared
as described elsewhere (19). Invertase antiserum was prepared as described by
Esmon et al. (20). Specific antibody was obtained in a two-step procedure.
Antiserum was treated first with intact SUCO cells to remove antibody against
carbohydrate; antibody directed against the protein portion was then affinity
purified by absorption and elution from invertase conjugated to Sepharose 4B.
PBS is 0.2 M NaCl, 12.5 mM potassium phosphate (pH 7.6). Spheroplasting
medium is 1 .4 M sorbitol, 25 mM potassium (or sodium phosphate (pH 7.5),
2 MM MgC12, 10 mM sodium azide, 40 mM fl-mercaptoethanol, and 50 U of
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lyticase per ODD U of cells. Dilution buffer is PBS with 2% Triton X-100.
Reaction buffer is 2.5% Triton X-100, 0.5 M NaCl, I mM magnesium chloride,
20 mM triethanolamine.HCI (pH 7.5). Wash buffer is 0.5 M NaCl, 0.05%
SDS, 20 mM triethanolamine-HCI (pH 7.5).
Isolation of Secretory (sec) Mutants:
￿
Mutants were isolated by
the density enrichment procedure of Novick et al. (11). Strains that failed to
accumulate or secrete active invertase upon derepression at 37°C were put into
complementation groupsby standard genetic techniques. A memberfrom each
group that showed minimal secretion of invertase at 37°C was analyzed for
protein synthesis by measuring the incorporation of"SO,'- into acid-insoluble
material (l0). Strains that synthesized protein at -50% or more of the wild-
type (X2180) rate at 37°C were candidates for secretory mutants.
Immune Precipitation and Electrophoresis:
￿
For invertase im-
munoprecipitation, cells were grown to early exponential phase in minimal
medium supplemented with 100 pM (NH4)2S04 and 5% glucose. Aliquots (-2
OD6w U) were incubated at 24` or 37°C for 30 min, sedimented in a table top
clinical centrifuge, and resuspended in 0.6-1 ml ofmedium containing 25-50
AM (NH4)2SO4 and 0.1% glucose. The incubation was continued at the same
temperature for 30 min to 1 h in the presence of400-750 ACi of 355042-. These
conditions allow efficient radiolabeling of invertase which is derepressed in
medium containing low glucose. Labeled cells were centrifuged and washed
once with cold 10 mM sodium azide. Tunicamycin (5-10 Ag/ml), when used,
was included during the 30 min incubation prior to the change in medium,
and during the subsequent labeling period.
Cell lysates were prepared by one of two lysis procedures; rapid lysis with
glass beads or conversion to spheroplasts with lyticase. In the rapid lysis
procedure, cell pellets were mixed with 0.15 g glass beads (0.3-0.5 mm) and 30
AI of I % SDS, broken bybeing vortexed for 90 s at 4°C, and then immediately
heated in a boiling water bath for 3 min. Lysates were diluted with 0.8 ml of
dilution buffer and centrifuged at 27,000 g for 20 min. Aliquots (0.7 ml) of
each sample were treated with 1 A1 ofaffinity-purified antibody (2.9 mg/ml)
and incubated at 0°C for 16-18 h. In the enzymatic lysis procedure, cells were
resuspended in 0.2 ml of spheroplasting medium and incubated for 60 min at
30°C. The spheroplast supernatant and pellet fractions were separated by
sedimentation at 3,000 g for 10 min. The pellet was resuspended in 0.1 ml of
1 % Triton X-100, or in 50 mM sodium phosphate (pH 7.5), or solubilized by
heating in I % SDS. Samples lysed in Triton X-100 were diluted with an equal
volume of 2x PBS containing 2 mM each of phenylmethylsulfonyl fluoride
and tosyllysine chloromethyl ketone. Samples lysed with SDS werediluted with
0.8 ml of dilution buffer. All lysates were centrifuged at 27,000 g for 20 min.
The spheroplast supernatant fraction was adjusted to 0.6 ml with PBS, Triton
X-100, phenylmethylsulfonyl fluoride, and tosyllysine chloromethyl ketone
(final concentrations 0.66x, 1%, I mM, and 1 mM, respectively), and centri-
fugedat 100,000 g for 90 min. The final supernatant fractions were mixed with
l-6 A1 of affinity-purified invertase antibody (2.9 mg/ml) in Eppendorftubes
and incubated at 0°C for 16-18 h. Mixtures were treated with fixed S. aureus
cells (75 Al ofa 10% [wt/vol] suspension was used for spheroplast supernatant
fractions and 25 AI for spheroplast lysates) and the immune precipitates were
washed as described elsewhere (21). In a control immune competition experi-
ment, twice the number of cells were used and the lysate was split; antibody
preincubated with 10 kg of purified invertase was added to one-half of the
fraction. Protein bands that were competed with purified invertase were not
competed with bulk mannan isolated from an invertase mutant strain (not
shown), indicating that the antibody was directed against the protein and not
the carbohydrate portion of invertase. Final pellets were resuspended in a
volume of SDS gel sample buffer that was proportional to the incorporation of
35SO42- into cells; this corrected for variations in the rate ofprotein synthesis
among different cultures. Suspended immunoprecipitates were heated in a
boiling water bath for 3 min, fixed S. aureus cells were sedimented, and the
supernatant samples were transferred to new tubes. Electrophoresis was per-
formed by the Laemmli procedure (22) or, for 10% polyacrylamide SDS slab
gels (13.7 x 16.7 cm), a modified procedure was used (23). Molecular mass
standards were: RNA polymerase (a-subunit, 39 kdalton; 0-subunit, 155 kdal-
ton; ,B' subunit, 165 Walton), phosphorylase a (94 kdalton), BSA (68 kdalton),
ovalbumin (43 kdalton), carbonic anhydrase(30 kdalton), and trypsin inhibitor
(21 .5 kdalton). Gels were stained for protein and treated with Enhance accord-
ing to the procedure described by New England Nuclear.
Glycosylated forms of invertase were evaluated by treatment with endo H
as described by Esmon et al. (20), or by binding to ConA-Sepharose 4B. In the
latter procedure, radiolabeled cells were converted to spheropass which were
lysed with 1% Triton X-100 as described above. The Triton-insoluble fraction
was resuspended in 25 tel of I% SDS, heated in a boiling water bath for 3 min,
and diluted with 0.4 ml of reaction buffer. After centrifugation for 30 min at
27,000 g, half ofthe soluble fraction was mixed with ConA-Sepharose (40 Al)
and agitated for 3 h at 24°C. The ConA-Sepharose was then sedimented; the
supernatant fraction was set aside and the pellet fraction was washed threetimes with 0.5 ml ofwash buffer, resuspended in 50 AI of 1% SDS, and heated
for 3 min in a boiling water bath. Dilution buffer (0.2 ml) was added and the
sample was centrifuged for 5 min in an Eppendorf microfuge. Dilution buffer
(0.2 ml) was also added to the ConA-Sepharose nonbinding fraction, and to
the sample that was not treated with ConA-Sepharose. Invertase was immu-
noprecipitated and electrophoresed as above.
For carboxypeptidase Y (CPY) immunoprecipitates, cells were grown in
minimal medium supplemented with 50 AM (NH4)2SO4 and 2% glucose. The
incubation conditions were the same as described above except that cells were
incubated for l h at 24°C, or 37*C in the presence of 200 ACi of 35SO42-, in
fresh minimal medium supplemented with 50 AM (NH4)2S04 and 2% glucose.
Cell lysates were prepared by the rapid lysis procedure. Supernatant fractions
were incubated with 2-4A1 ofantibody (1 mg/ml) for 2 h at 0'C. Samples were
treated with S. aureus, washed, solubilized, and electrophoresed as described
above.
Enzyme Assays and Other Procedures:
￿
External invertase was
assayedaspreviouslydescribed (24); 1 U isdefinedas l Amol ofglucose released
per min. Cytoplasmic invertase was assayed in spheroplast lysates as described
by Novick and Schekman (10). External acid phosphatase was assayed as
described by van Rijn, Boer, and Steyn-Parve (25); 1 U is defined as 1 nmol of
p-nitrophenol released per minute. Sulfate permease was assayed as described
by Breton and Surdin-Kerjan (26); 1 U is defined as 1 nmol of 5042- taken up
per minute. Radioactivity was measured in a Searle Delta 300 liquid scintilla-
tion counter. Treatment ofyeast cellswithtrinitrobenzenesulfonic acid (TNBS)
and evaluation oftrinitrophenol(TNP)-tagged "S-labeled proteinsaredescribed
elsewhere (27). Electron microscopy was performed by the method of Byers
and Goetsch (28).
RESULTS
Secretory Mutants That Do Not
Accumulate Active Invertase
The enrichment procedure used to isolate yeast secretory
mutants requires that cells become dense at 37°C. This tech-
nique appears to enrich for cells that continue macromolec-
ular synthesis without a corresponding increase in cell size or
number (11). Of the original 485 isolates that failed to secrete
invertase and acid phosphatase, only 190 accumulated active
invertase at 37°C; these were called class A sec mutants.
Standard genetic techniqueswere used to arrange the remain-
ing mutants into 34 complementation groups. Nearly 70% of
the mutants were in two groups, 18 groups had more than
one member, and 16 groups had one each. The mutants were
then screened for defects in protein synthesis. Only five of the
groups had members that synthesized protein at -50% or
more of the wild-type (X2180-1A) rate at 37°C; these were
considered candidates for a new classof secretory mutants.
S. cerevisiaeproduces two forms of invertase: a constitutive
nonglycosylated form that is located in the cytoplasm, and a
heavily glycosylated form that is secreted into the cell wall
and is under hexose repression (29). The constitutive form is
not a precursor of the secreted enzyme (13). In spite of these
differences, both enzymes are products ofthe same gene (15,
30, 31). Secretory mutations should affect the production of
active secretory forms of invertase, but not the cytoplasmic
enzyme. Candidates for secretory specific defects were grown
in repressing medium (YP + 5% glucose) at 24°C. Cells were
incubated at 37*C for 30 min before invertase synthesis was
derepressed by transfer into YP medium + 0.1% glucose at
37*C for 90 min. External invertase was assayed in whole
cells, and intracellular forms of invertase were assayed in
spheroplast lysates (10). All five of the sec mutant candidates
secreted nearly normal levels of invertase at 24°C, but at 37*C
showed a threefold or greater difference between the rates
(normalized to wild type) of protein synthesis and invertase
secretion. Unlike the class A sec mutants (secl example in
Table 1), the new mutants did not accumulate derepressed
invertase activity. However, cytoplasmic invertase was pro-
duced in four of the five selected mutants when cells were
incubated at 37*C in repressing medium. The mutants that
synthesized cytoplasmic but not secretory invertase were
called the classB sec mutants (sec53, sec55, sec58, and sec59).
Of the class B sec mutants only sec53 and sec59 will be
considered. Data on the synthesis ofsecretory and cytoplasmic
forms of invertase, and protein synthesis in these mutants in
comparison to X2180-1A and secl are presented in Table 1.
By immunoprecipitation analysis sec55 and sec58 produced
and secreted immunoreactive, highly glycosylated forms of
invertase. We have not determined if the invertase secreted
in sec55 and sec58 becomes inactive during or after export,
or fails to fold correctly during synthesis.
In genetic crosses with the parent strain, mutants of each
group were recessive and showed 2:2 segregation of the tem-
perature-sensitive phenotype which always coincided with the
TABLE I
Class B sec Mutants: Secretory and Cytoplasmic Forms of Invertase and Protein Synthesis
(5 Ag/ml)
*Cells were grown to early exponential phase in YP medium + 5% glucose at 24"C. Samples (2 OD. U of cells) were incubated for 30 min at 37*C,
sedimented in a clinical centrifuge, resuspended in 2 ml of YP medium + 0.1% glucose, and incubated for an additional 90 min at 37°C. Parallel samples
were incubated at 24°C. At the end of the experiment, cells were sedimented and resuspended in 1 ml of cold 10 mM sodium azide. Cell aliquots (0.5 ml)
were sedimented and resuspended in 0.13 ml of spheroplasting medium. Spheroplasts formed after a 60 min incubation at 30'C were sedimented at 3000 g
for 10 min and the pellet was resuspended in 0.5 ml of 1% Triton X-100. External invertase was assayed in whole-cell aliquots and internal invertase was
measured in the spheroplast lysates.
* Incubations were initiated as in *, except 0 time samples (2 OD. U) were collected and the incubation at 37*C was performed in fresh YP medium + 5%
glucose for 2 h. Invertase activity in spheroplast lysates was measured and the unit ratios of the 2 h/0 h samples are presented.
' Cells were grown overnight in minimal medium (16) supplemented with 10 AM ammonium sulfate and 2% glucose. Cells (1 .5 OD600 U) were sedimented and
resuspended in 1.5 ml of fresh medium, and incubated at 37°C for 30 min. Label (0.1 gCi of `SO,'-) was added to 1 ml of each sample and the incubation
was continued for 90 min; the remaining 0.5 ml was used to normalize the incorporation rate to cell absorbance. Incubations were stopped with 1 ml of cold
20% trichloroacetic acid and incorporation was measured in samples collected onto Whatman GF/A filters (Whatman Laboratory Products Inc., Clifton, NJ).
r SF402-4D was derived from a cross of HMSF 392 (original isolate) and X2180-1A.
FERRO-NOVICK ET AL .
￿
Class 8 Yeast Secretory Mutants
￿
37
Strain sec
Number
of isolates
External
(90 min 37°C)
Derepressed invertase*
Internal
(90 min 37°C) (90
External
min 24°C)
Cytoplasmic
invertase*
(2 h/0 h 37°C)
Protein synthe-
siss (% rate rel-
ative to X2180)
U/mg dry wt
X2180-lA (wild type) - 0.36 0.067 0.253 1 .63 100
HMSF 331 53-6 16 0.067 0.08 0.267 1 .56 50
S F402-4 DI 59-1 1 0.047 0.073 0.213 1 .68 68
HMSF 1 1-1 - 0.047 1 .3 0.207 1 .57 -
X2180-1 A + tunicamycin - 0.02 0.06 - 1 .4 90secretory defect (data not shown) . The class B sec mutants
were not allelic with any of the class A mutants, and thus
represent an independent set ofcomplementation groups .
Immunoreactive Invertase Accumulated in
sec53 and sec59
Immunoprecipitation was performed to test the possibility
that enzymatically inactive forms of invertase are produced
but not secreted in the class B mutants. The analysis was
aided by the use ofa high copy number plasmid that contains
the invertase gene (SUC2) on an insert (15). Mutant and
wild-type transformed cells were derepressed and radiolabeled
with `S04Z- for 30 min . Immunoreactive forms of invertase
were examined in mutant cells that had been converted to
spheroplasts with lyticase (10, 18) . In this procedure, secreted
proteins are released, and accumulated proteins are retained
within the spheroplast . Derepressed invertase cross-reactive
material was detected in spheroplast lysates from cells labeled
at 37°C but not at 24 °C (Fig. 1, lanes 1-5) . sec53accumulated
heterogeneous forms ranging from 60-64.5 kdalton (Fig. 1,
lane 1), while sec59produced several closely migrating protein
species ranging from 60 to 66 kdalton (Fig. 1, lane 3) . A 60-
kdalton species, representing cytoplasmic invertase (32), was
detected in spheroplasts from cells labeled at 24°C (Fig. 1,
lanes 2 and 4) . At 24°C both sec53 and sec59 secreted active
invertase that had an electrophoretic mobility similar to the
wild-type enzyme (Fig . 1, lanes 6-8). At 37 °C only the spher-
oplast supernatant fraction from wild-type cells contained
FIGURE 1
￿
Immunoprecipitation of accumulated and secreted in-
vertase in sec53 and sec59 at 37° and 24°C . Cell lysates were
prepared by the enzymatic lysis procedure . Samples were electro-
phoresed on a SDS 10% polyacrylamide slab gel (23) . A fluorograph
of the gel is shown . Spheroplast lysates : (lane 1) sec53 (SF649-2A/
pRB58) 37°C ; (lane 2) sec53, 24°C ; (lane 3) sec59 (SF629-3C/pRB58)
37°C ; (lane 4) sec59, 24°C ; (lane 5) wild type (SF610-7B/pRB58)
37°C . Spheroplast supernatants: (lane 6) sec53, 24°C ; (lane 7) sec59,
24°C; (lane 8) wild type, 24°C ; (lane 9) sec53, 37°C; (lane 10) sec59,
37°C ; (lane 11) wild type, 37°C .
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FIGURE 2 Binding of invertase cross-reacting material to ConA-
Sepharose . SDS soluble fractions were mixed with ConA-Sepha-
rose . Invertase in untreated, ConA-Sepharose-bound, and -un-
bound fractions was immunoprecipitated and analyzed by SDS gel
electrophoresis . A fluorograph of the gel is shown .
immunoreactive invertase (Fig. l, lanes 9-11) . Immune pre-
cipitation of all species was inhibited effectively by competi-
tion with excess unlabeled invertase (data not shown) .
The electrophoretic mobility of accumulated invertase pre-
cursors suggested partial glycosylation. When transport from
the ER is blocked in a class A sec mutant, accumulated
invertase has a mobility corresponding to -80 kdalton ; -20
kdalton is accounted for by 9-10 N-linked core oligosaccha-
rides (20, 33). The carbohydrate content of forms accumu-
lated in the class B sec mutants was examined by binding to
conA and by sensitivity to endo H . Mutant and wild-type
cells were labeled with 35SO4Z- at 37°C, converted to sphero-
plasts, and lysed with 1 % Triton X-100 . The insoluble frac-
tion, which contains the accumulated forms ofinvertase (see
accompanying paper), was dissolved in 1% SDS, and the
soluble material was diluted in a Triton-containing buffer and
mixed with ConA-Sepharose 4B . Proteins that bound to the
immobilized lectin were separated from unbound material by
sedimentation . The bound fractions were solubilized again
with SDS, and compared with unbound and untreated frac-
tions after immunoprecipitation of invertase . Fig. 2 shows a
fluorograph ofthe species resolved bySDS gel electrophoresis .
Most of the invertase in sec53 did not bind to ConA-Sepha-
rose ; the small amount that did bind (-10%) migrated as a
species of-64 kdalton. The multiple species accumulated in
sec59 showed unequal affinity for ConA-Sepharose : forms of
66 and 64.5 kdalton were bound, some of the 63-kdaltonform was bound, and none ofthe 60-kdalton form was bound.
As a control, wild-type cells were treated with tunicamycin, a
drug that blocks N-linked oligosaccharide synthesis (34, 35) .
The 60-kdalton species in tunicamycin-treated cells did not
bind to ConA-Sepharose, while a minor form at 63 kdalton,
which probably results from incomplete inhibition of oligo-
saccharide synthesis, was quantitatively bound (Fig. 2) .
EndoH cleaves between the two N-acetylglucosamine units
that connect N-glycosidically linked oligosaccharides to yeast
mannoproteins (36). When invertase from wild-type cells was
treated with endo H, a 63-kalton form was produced which
represents a 60-kdalton polypeptide with 9-10 remaining
G1cNAc residues (Fig . 3). In addition to a 60-kdalton species,
an endo H-resistant form of ~63 kdalton persisted in inver-
FIGURE 3 Endo H treatment of immunoreactive invertase . SDS
soluble fractions of invertase from wild-type and mutant cellswere
treated with or without endo H and analyzed by SDS gel electro-
phoresis . A fluorograph of the gel is shown.
(100 Wg/m l)
TABLE II
tase from sec59. Endo H treatment had no effect on the
diffuse mobility of the invertase band from sec53 . Thus by
the ConA-Sepharose and endo H-sensitivity criteria, the in-
vertase in sec53 had very little carbohydrate, while 2-3 ofthe
invertase species accumulated in sec59 were glycosylated .
Other Cell Surface-related Defects in
sec53 and sec59
The number ofcells and buds remained nearly constant in
cultures of mutants incubated for 2 h at 37°C (data not
shown) . As expected from the enrichment procedure, the halt
in bud emergence was accompanied by an increase in cell
density (data not shown) .
The phenotype of sec53 and sec59 was mimicked to some
extent by treatment of wild-type cells with tunicamycin. The
drug blocks formation of active secretory invertase without
affecting production ofthe cytoplasmic enzyme (13 ; Table 1) ;
it also caused cells to become dense (data not shown). Thus,
the density enrichment may have selected for mutants that
failed to synthesize or transfer oligosaccharides to protein .
Yeast mannoprotein oligosaccharide synthesis may be mea-
sured directly by the incorporation of ['H]mannose into
ethanol precipitable material (37). Control experiments
showed that synthesis was nearly completely blocked by in-
hibition of protein synthesis with cycloheximide, while tuni-
camycin allowed a reduced level of incorporation (Table 1I) .
sec53 and sec59 showed a significant reduction in mannose
incorporation at 37*C but not at 24°C. The initial rate of
['H]mannose permeation into intact cells was not reduced at
37*C in sec53 (not shown), indicating thatmannose transport
was not affected .
Two other cell surface markers whose export is blocked in
the class A sec mutants (11) were examined in the class B
mutants . Acid phosphatase, a cell wall glycoprotein, began to
derepress in X2180-1A 2-t/2 h after a shift from phosphate-
rich to phosphate-depleted growth medium . Secretion was
measured during the period from 2.5 to 5 h after the medium
shift . The sec mutants secreted normally at 24°C, but showed
a dramatic reduction in the amount ofactive acid phosphatase
secreted at 37°C. As with invertase, acid phosphatase produc-
tion was blocked by tunicamycin (Table 1I) . To assess plasma
Oligosaccharide Synthesis andAcid Phosphatase and Sulfate Permease Export in Class B sec Mutants
* Cells were grown overnight in minimal medium supplemented with 0.5% casamino acids, 1 .8% galactose, and 0.2% glucose . Cells (5 .5 OD. U) were
sedimented and resuspended in 1 .1 ml of fresh medium . The cultures were incubated at 37°C for 30 min. ['H]mannose (2 JACi) was added to 1 ml of each
sample and incubated for an additional 90 min at 37°C ; the remaining 0.1 ml was used to normalize the incorporation rate to cell absorbance . Parallel
incubations were performed at 24°C. Cells were collected and washed with azide . Spheroplasts were prepared as described in the legend to Table I and
lysed with water . Mannoproteins were precipitated with ethanol (final concentration 70%) . The insoluble material was collected and counted as previously
described (20).
4 Experiment and enzyme assaywere performed as previously described (11).
s Experiment and assaywere performed as previously described (11), except starting cultures were grown with 0.1 mM (NH4),SO4 .
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Strain sec
Mannose
(% rate
24°C
incorporation*
relative to X2180)
37°C 2.5 h
Acid phosphatase=
5 h (37°C) 5 h (24°C)
Sulfate
24°C
permeases
37°C
U/ml U/mg dry wt
X2180-1A 100 100 19 145 165 5.6 3.9
HMSF331 53-6 98 7 23 23 178 5 .5 0.16
SF402-4D 59-1 102 29 30 31 143 5 .1 0.6
X2180-lA + tunicamycin - 21 29 37 - 5.6 3.6
(5 Ag/ml)
X2180-1A + cycloheximide - 4membrane assembly, the appearance of an inducible per-
mease activity was analyzed (10) . Sulfate permease is dere-
pressed during a 2.5-h incubation in sulfate-free growth me-
dium (10) . Although sulfate permease activity appeared in the
mutants during derepression at 24°C, it was significantly lower
at 37°C (Table II) . In contrast to invertase and acid phospha-
tase, sulfate permease derepression was not affected by treat-
ment of wild-type cells with tunicamycin.
Treatment of cells with TNBS tags surface proteins with
TNP groups; precipitation with anti-TNP IgG allows selective
recovery of tagged proteins from a spheroplast supernatant
fraction (27, 38) . Four major secreted proteins are not ex-
ported at 37°C in representative class A sec mutants (27) . The
same test was repeated with sec53 and sec59. Cells were
incubated at 25° or 37°C for 30 min, labeled with 315042- for
45 min at the same temperature, and tagged with TNBS at
0°C as previously described (27). Treated cells were converted
to spheroplasts, and TNP-tagged proteins were immunopre-
cipitated from the spheroplast supernatant fraction . Aliquots
of solubilized precipitates were analyzed by SDS gel electro-
phoresis and fluorography . Fig. 4 shows that wild-type cells
at 37° and 25°C, and sec mutant cells at 25°C, secreted the
same set of surface proteins : S, (>250 kdalton), S 2 (140
kdalton), S3 (51 kdalton), and S4 (33 kdalton) . Proteins S,-S4
FIGURE 4
￿
Transport of major secreted proteins. Cells were radio-
labeled at 37 or 25°C, tagged with TNBS at 0°C, and converted to
spheroplasts as previously described (27) . Secreted proteins tagged
with TNP were immunoprecipitated with TNP antibody and solu-
bilized immunoprecipitates were evaluated by electrophoresis on
an SIDS 12% polyacrylamide gel . A fluorograph of the gel is pre-
sented . (lane 1) sec53-11 (HMSF 375) 37°C ; (lane 2) sec59 (SF402-
4D) 37 °C ; (lane 3) wild type (X2180-1A) 37°C ; (lane 4) sec53, 25°C ;
(lane 5) sec59, 25°C ; (lane 6) wild type, 25°C .
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FIGURE 5 Immunoprecipitation of carboxypeptidase Y . Samples
were electrophoresed on a SDS 7.5% polyacrylamide slab gel . (lane
1) pep4-3 treated with tunicamycin, 37°C ; (lane 2) wild type (X2180-
tA) treated with tunicamycin, 37°C ; (lane 3) sec53 (HMSF 331)
37'C ; (lane 4) sec59 (SF402-4D) 37°C ; (lane 5) wild-type, 37°C ;
(lane 6) pep4-3, 37°C .
were not exported at 37°C in the mutants . Instead, immuno-
precipitates contained a series of proteins that appeared un-
related to proteins detected under permissive incubation con-
ditions . These proteins, which we suspect are of cytoplasmic
origin, were also detected in the cell wall fraction of class A
see mutants radiolabeled at 37°C (27) . A small and variable
percentage of sec mutant cells become permeable during
incubation at 37°C . Subsequent TNBS treatment allows tag-
ging of intracellular proteins that are released when cells are
converted to spheroplasts .
Influence on Vacuolar Glycoprotein Synthesis
The yeast vacuole contains a distinct set of glycoproteins,
many ofwhich are hydrolytic enzymes with acid pH optima .
One of these, CPY, is transported to the vacuole as a proen-
zyme with a polypeptide molecular mass of 59 kdalton and
N-glycosidically linked oligosaccharides which account for an
additional 10 kdalton (39) . Localization of the proenzyme
requires part of the secretory pathway: class A sec mutants
that accumulate ER or Golgi bodies block proCPY transport
(19). Within the vacuole, proteolytic activation of CPY re-
moves an 8 kdalton amino-terminal propeptide in a reaction
that requires thePEN gene product (19, 40) .
The effect ofthe class B sec mutants onCPY synthesis and
maturation was examined by immunoprecipitation with affin-
ity-purified antibody directed against the CPY protein por-
tion . An immunoreactive form with the mobility of ungly-
cosylated proCPY (59 kdalton) was produced in sec53 and
sec59 (Fig . 5, lanes 3 and 4) at 37°C, while mature CPY (61
kdalton) was produced at 24°C in these mutants (data not
shown) . The 59-kdalton form was also produced when wild-
type (X2180-1A) or proCPY processing mutant (pep4) cells
were treated with tunicamycin at 37°C (Fig . 5, lanes 1 and 2);
these conditions delay, but do not prevent, transport of un-
glycosylated proCPY to the vacuole (19) . At 37°C in the
absence of tunicamycin, wild-type and pep4 cells produced
the expected 61 (Fig. 5, lane 5) and 69-kdalton proCPY (Fig .TABLE III
Invertase in Double sec Mutants
*Cultures were grown in YP + 5% glucose medium at 24°C to an
A6w of 0.5-1 .5. Cells (2 OD6w U) were incubated at 37°C for 1 h,
sedimented in a clinical centrifuge, and resuspended in 1 ml of
YP + 0.1% glucose medium. The incubation was continued for
90 min at 37°C, after which the cells were chilled, sedimented,
and resuspended in 10 mM sodium azide. Cells were converted
to spheroplasts and accumulated invertasewas assayed as before
(11).
5, lane 6), respectively;these forms reach the vacuole normally
at 37°C (19).
Mutations Block Early in the Secretory Pathway
Yeast secretory mutants that accumulate active secretory
enzymes (class A sec) define a pathway of ER --+ Golgi body
-* vesicle --> cell surface (11, 21). This pathway was deter-
mined in part by the demonstration that mutations affecting
early stages are epistasic to mutations that block later stages.
By this analysis, transport from the ER is the earliest step
defined in class A sec mutants. If sec53 (or see59) blocks a
step before the one blocked in sec18 (an ER-accumulating
class A mutant), then double sec mutants should fail to
accumulate active invertase at 37°C. Alternatively, if sec53
(or see59) leads to inactivation ofinvertase at a stage subse-
quent to the ER, double mutants should accumulate active
invertase. Wild-type, sec18, sec18 sec53, and sec18 see59
strains were derepressed for invertase at 37*C for 90 min.
Cells were converted to spheroplasts to release secreted en-
zymes, and accumulated invertase was assayed in spheroplast
lysates. Table III shows that much less invertase was accu-
mulated in the double mutants than in sec18alone. The level
in the double mutants was comparable to the amount found
in the wild-type lysate, most of which corresponds to cyto-
plasmic invertase (32). Thus, sec53 and see59 are epistasic to
sec18.
Thin sections of sec53 and see59 cells grown at 25° and
37*C were examined in the electron microscope to assess the
cytologic consequences of these lesions. Wild-type cells show
short, thin tubules ofER which occasionally connect with the
nuclear envelope (11). When transport from the ER is blocked
in a class A sec mutant, the ER tubules and the nuclear
envelope expand and the ER winds more extensively through
the cytoplasm (11). In contrast to this, see59 showed frag-
mented ER tubules of variable width; fragmentation of the
nuclear envelope was also observed (Fig. 6A). Mutant cells at
25*C (Fig. 6B), and wild-type cells treated with tunicamycin
(not shown) appeared normal. sec53 was not as obviously
altered as see59, although some cellsshowed rounded vesicles
in place of thin ER tubules (not shown).
DISCUSSION
We have identified new yeast secretory mutants that are
defective in the processing and transport ofexported proteins.
The mutants are temperature-sensitive for the production of
active secretory forms of invertase and acid phosphatase, but
not for the synthesis of active cytoplasmic invertase. These
mutants (secS3, see59) are distinct from our previously re-
ported sec mutants which block export, but not synthesis, of
active secretory enzymes (secl-sec23) (11). A block early in
the secretory pathway in sec53 and see59 is suggested by the
incomplete glycosylation of invertase (Figs. 1-3) and by the
epistasis of these mutants to sec18, a mutant that blocks
transport of active invertase from the ER to the Golgi body
(Table III).
Although the mutants do not appear to accumulate mem-
brane, such as is seen in class A sec mutants, the morphology
of the ER in see59 is distinct (Fig. 6). Both the ER and the
nuclear membrane are fragmented in contrast to the smooth
thin tubules that are seen in sections of wild-type cells. The
membrane is not permanently damaged or open, because
accumulated invertase precursor is matured and secreted
upon return to the permissive temperature (42). Distortion of
the ER tubules may result from accumulation of abnormal
amounts of partly glycosylated proteins, embedded in or
tightly associated with the ER membrane (42).
Invertase cross-reacting material produced in sec53 and
see59 at 37*C ranges from 60-66 kdalton (Fig. 1). In vitro
translation studies have shown that invertase is synthesized
as a precursor with a leader sequence of -2 kdalton (23).
When invertase mRNA is translated in the presence of dog
pancreas microscmes, the leader sequence is cleaved, and 9-
10 carbohydrate chains are added to the molecule as it pene-
trates into the lumen of the ER (23, 42). Each core carbohy-
drate chain adds -2 kdalton to the protein portion ofinvertase
which is 60 kdalton. Both sec53 and see59 accumulate forms
ofinvertase that are >60 kdalton. The diffuse species in sec53
(60-64 kdalton) appears not to contain N-linked carbohy-
drate: it does not bind to ConA-Sepharose and is not reduced
in size by treatment with endo H (Fig. 2 and 3). This form
may retain the signal peptide and be modified in some other
way to account for a diffuse SDS gel mobility. see59 accu-
mulates four species (60, 63, 64.5, 66 kdalton): the largest
three contain N-linked oligosaccharides, although most of the
63-kdalton species is not glycosylated; the 63-kdalton form
may contain the signal sequence. The simplest interpretation
of this result is that the see59 mutation causes invertase
penetration to arrest after the addition of 0-3 core oligosac-
charides. Current evidence suggests that oligosaccharide trans-
fer from dolichol to polypeptide occurs on the lumenal surface
of the ER. Thus, it seems likely that an initial portion of the
invertase polypeptide penetrates into the ER lumen in see59.
This possibility is considered further in the accompanying
paper (42).
Invertase and CPY differ in the number of protein species
that accumulate in see59. Although CPY has four N-linked
oligosaccharides, only one band, with a mobility correspond-
ing to unglycosylated proCPY, accumulates in see59 (Fig. 5;
39, 11, 10). Indirect evidence suggests that CPY has an amino-
terminal 8-kdalton propeptide that is devoid of carbohydrate
(40). DNA sequence analysis shows that invertase, in contrast
to CPY, has a potential N-glycosylation site at position four
of the mature protein sequence (43). Thus, assuming the
amino terminus penetrates first across the ER membrane,
invertase would present a site for glycosylation shortly after
the polypeptide enters the lumen. CPY would not present a
glycosylation site until at least 8 kdalton ofprotein had been
translocated.
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Strain Genotype Invertase*
Ulmg drywt
X2180-1A wild type 0.15
SF 282-2A sec-18 0.85
SF 502-7A secl8, sec53 0.24
SF 615-2A secl8, see59 0.29The behavior of a biosynthetic precursor ofthe pheromone
a-factor is consistent with this pattern . DNA sequence analysis
shows that all three potential N-glycosylation sites are in the
amino-terminal 40% of an 18-kdalton pro-a-factor (44) . As
expected from the above hypothesis, sec59 accumulates four
immunoreactive species with sizes that correspond to precur-
sorscontaining 0-3 oligosaccharides (D . Julius, R. Schekman,
and J . Thorner, unpublished results) .
Theglycosylation ofproteins can be interrupted by blocking
oligosaccharide synthesis directly, such as with tunicamycin,
or indirectly by blocking transport ofthe protein into theER .
Although some of the properties of sec53 and sec59 are
mimicked by treatment of wild-type cells with tunicamycin,
sulfate permease export is blocked in the mutants but not in
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FIGURE 6 Thin section electron
micrographs of sec59 (SF409-4D)
cells . Cells were grown in YPD
medium at (A) 37°C for 3 h and
(S) 24°C . ER, endoplasmic retic-
ulum ; NM, nuclear membrane .
Bar, 0.5 gm .
drug-treated cells (Table 11) . Thus, as the mutations and the
drug have different effects, they are unlikely to affect the same
process . From this we infer that sec53 and sec59 are not
directly defective in oligosaccharide synthesis. In support of
this concusion, major cell surface proteins that are exported
in tunicamycin-treated cells at 25° (27) or 37°C (P . Novick
and R . Schekman, unpublished results) are not secreted in
sec53 and sec59 at 37°C (Fig. 4).
Inhibition ofmaturation and transport ofsecretory, plasma
membrane, and vacuolar enzymes in sec53 and sec59 identi-
fies acommon step in the translocation ofpolypeptides across
the ER membrane in yeast, as has been shown for analogous
proteins in mammalian cells (45, 46) . In the accompanying
report we provide evidence that this common step occurswhen the transported polypeptide enters the ER membrane.
We thank Sharon Fried for early assistance in identifying the classB
secmutants, Irene Schauerfor hergenerous assistance with theendo
H experiment, and Marian Koshland and Mayummi Yagi fortheir
excellent suggestions on the use of antibodies. We thank Marian
Carlson and David Botstein for generously providing the invertase
plasmid, Tom Stevens for providing carboxypeptidase Y antibody,
and acknowledge discussions with Dan Perlman and Scott Emr. We
also thank PeggyMcCutchan fortyping this manuscript.
This work wassupportedby grants from theNational Institutes of
Health (General Medical Sciences and Environmental Health Sci-
ences) andthe National Science Foundation.
Received for publication 28 March 1983, and in revised form
1 September 1983.
REFERENCES
1. Blobel,G., and B. Dobberstein. 1975. Transferofproteinsacrossmembranes. I. Presence
of proteolytically processed and unprocessed nascent immunoglobulin light chains on
membrane-bound ribosomes ofmurine myeloma. J . CellBiol. 67:835-851.
2. Wickner, W. 1980. Assembly of proteins into membranes. Science (Wash. DC).
210:861-868.
3. Engelman, D. M., and T. A. Steitz. 1981. The spontaneous insertion of proteins into
and across membranes: the helical hairpin hypothesis. Cell. 23:411-442.
4. Von Heijne, G., and C. Blomberg. 1979. Transmembrane translocation of proteins.
Eur. J. Biochem. 97:175-181.
5. Katz, F. N., J. E. Rothman, V. R. Lingappa, G. Blobel, and H. F. Lodish. 1977.
Membrane assembly in vitro: synthesis, glycosylation, and asymmetric insertion of a
transmembrane protein. Proc. Nad. Acad. Sci. USA. 74:3278-3282.
6. Walter, P., and G. Blobel. 1981. Transloation of proteins across the endoplasmic
reticulum. If. Signalrecognition protein (SRP) mediates selective bindingtomierosomal
membranesofin-vitro-assembled polysomessynthesizing secretary protein.J. Cell Biol.
91:551-556.
7. Walter, P., andG. Blobel. 1982. Signal recognition particlecontains a 7s RNAessential
for protein translocation across the endoplasmic reticulum. Nature (Land .). 299:691-
698.
8. Meyer, D. I., E. Krause, and B. Dobberstein. 1982. Secretary protein transloation
across membranes-the role ofthe 'docking protein'. Nature(Land.). 297:647-650.
9. Gilmore,R., G.Blobel, and P.Walter 1982.Protein transloationacrosstheendoplasmic
reticulum. II. Isolation and characterization ofthe signal recognition particle receptor.
J . Cell Biol. 95:470-477.
10. Novick, P., and R. Schekman. 1979. Secretion and cell-surfacegrowth are blocked in a
temperature sensitive mutant ofSaccharomycescerevisiae. Pros. Nail. Acad. Sci. USA.
76:1858-1862.
11. Novick, P., C. Field, and R. Schekman. 1980. Identification of 23 complementation
groupsrequired forpost-translationaleventsintheyeastsecretarypathway. Cell. 2I:205-
215.
12. Kiely, M. C., G. S. McKnight, and R. T. Schimke. 1976. Studies on the attachment of
carbohydratetoovalbuminnascent chains in the hen oviduct. J. Biol. Chem. 251:5490-
5495.
13. Gallili, G., and J. O. Lampen. 1977. Large and small invertase and the yeastcell cycle:
pattern ofsynthesis and sensitivity to tunicamycin. Biochem. Biophys. Acta. 475:113-
122.
14. Mizunaga, T., and T. Noguclii. 1982. The role ofcore oligosaceharide in formation of
an active acid phosphatase and its secretion by yeast protoplasts. J. Biochem. (Tokyo).
91 :191-200.
15. Carlson, M.,and D. Botstein. 1982. Twodifferentiallyregulated mRNAs with different
5' ends encodesecreted and intracellular forms ofyeast invertase. Cell. 28:145-154.
16. Wickerham, L.J. 1946.Acriticalevaluation ofthe nitrogenassimilation tests commonly
used in theclassification ofyeasts. J . Bacterial. 52:293-301 .
17. Rubin, G. M. 1973. The nucleotide sequence ofSaccharomyces cerevisiae 5.88 ribo-
somal ribonucleic acid. J. Biol. Chem. 248:3860-3875.
18. Scott, J., and R. Schekman. 1980. Lytiase: endoglucanase and protease activities that
act togetherin yeast cell lysis. J . Bacterial. 142:414-423.
19. Stevens, T., B. Esmon, and R. Schekman. 1982. Early stages in the yeast secretary
pathway are required for transport ofcarboxypeptidase Yto the vacuole. Cell 30:439-
448.
20. Esmon, B., P. Novick, and R. Schekman. 1981. Compartmentalized assembly of
oligosaccharides on exported glycoproteins in yeast. Cell. 25:451-460.
21 . Novick, P., S. Ferro, and R. Schekman. 1981 . Order of events in the yeast secretary
pathway. Cell. 25:461-469.
22. Laemmf, U. K. 1970. Cleavage of structural proteins during the assembly ofthe head
ofbacteriophage T4 . Nature(Loud .). 227:680-685.
23. Perlman, D., and H. Halvorson. 1981. Distinct repressible mRNAs forcytoplasmic and
secreted yeastinvertaseare encoded by a single gene. Cell. 25:525-536.
24. Goldstein, A., and J. O. Lampen. 1975. P-o-Fructofuranoside fructohydrolase from
yeast. Methods Enzymol. 42:504-511.
25. vanRijn, H.J. M.,P. Boer, andE. P.Steyn-Parv6. 1972.Biosynthesis ofacidphosphatase
ofbaker's yeast. Factors influencing its production by protoplasts and characterization
ofthe secreted enzyme. Biochim. Biophys. Acta. 268:431-441.
26. Breton, A. and Y. Surdin-Keijan. 1977. Sulfate uptake in Saccharomyces eerevisiae:
biochemicaland genetic study. JBacterial 132:224-232.
27. Novick, P., and R. Schekman. 1983. Export ofmajor cell surface proteins isblockedin
yeast secretary mutants. J. Cell Biol. 96:541-547.
28. Byers, B., and L. Goetsch. 1975. Behavior of spindles and spindle plaques in the cell
cycle and conjugation ofSaccharomyces cerevisiae. J . Bacterial. 124:511-523.
29. Gascon, S., N P. Neumann, and J. O. Lampen. 1968. Comparative study of the
properties of the purified internal and external invertases of yeast. J Biol. Chem.
243:1573-1577,
30. Carlson, M., B. C.Osmond, and D. Botstein. 1981. Mutants ofyeast defectivein sucrose
utilization. Genetics. 98:25-40.
31. Mizunaga, T., J. S. Tkacz, L. Rodriguez, R. A. Hackel, and J. O. Lampen. 1981 .
Temperature-sensitive forms of large and small invertase in a mutant derived from a
SUCI strain ofSaccharomycescerevisiae. Mol. Cell. Biol. 1:460-468.
32. Gascon, S., and J. O. Lampen. 1968. Purification ofthe internal invertase of yeast. J .
Biol. Chem. 243:1567-1572.
33. Trimble, R. B., and F. Maley. 1977. Subunit structure of external invertase from
Saccharomycescerevisiae. J Biol. Chem. 252:4409-4412.
34. Kuo, S.-C., and J. O. Lampen. 1974. Tunicamycin-aninhibitor of yeastglycoprotein
synthesis. Biochem. Biophys. Res. Commun. 58:287-295.
35. Tkacz, J. S., and J. O. Lampen. 1975. Tunicamycin inhibition of polyisoprenyl N-
acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. Biachem. Bio-
phys. Res. Commun. 65:248-257.
36. Chu, F. K., R. B. Trimble, and F. Maley. 1978. The effect ofcarbohydratedepletionon
the properties ofyeast external invertase. J. Biol. Chem. 253:8691-8693.
37. Hasihk, A., and W. Tanner. 1978. Biosynthesis of the vacuolar yeast glycoprotein
carboxypeptidase Y: conversion of the precursor into the enzyme. Eur. J . Biochem.
85:599-608.
38. Kaplan, G.,J. C. Unketess, and Z. A.Cohn. 1979. Insertion and turnover ofmacrophage
plasma membrane proteins. Proc. NadAcad. Sci. USA. 76:3824-3828.
39. Hasilik, A., and W. Tanner. 1978. Carbohydrate moiety of carboxypeptidase Y and
perturbation ofits biosynthesis. Eur. JBiochem. 91 :567-575.
40. Hemmings, B. A., G. S. Zubenko, A. Hasilik, andE. W. Jones. 1981. Mutant defective
in processing of an enzyme located in the lysosome-like vacuole of Saccharomyres
cerevisiae. Proc. Nail. Acad. Sci. USA. 78:435-439.
41 . Ferro-Novick, S., W. Hansen, I. Schauer, and R. Schekman. 1983. Genes required for
completion ofimport ofproteins into the endoplasmic reticulum in yeast. 98:44-53.
42. Chu, F. K., andF. Maley. 1980. The effect ofglucose on the synthesis andglycosylation
of the polypeptide moiety ofyeast external invertase. J Biol. Chem. 255:6392-6397.
43. Taussig, R., and M. Carlson. 1983. Nucleotide sequence ofthe yeast SUC2 gene for
invertase. NucleicAcidRes. 11:1943-1954.
44. Kurdjian, J., and l. Herskowitz. 1982. Structure ofa yeast pheromone gene (MFa): a
putative a-factorprecursorcontains fourtandem copiesofmature a-factor.Cell. 30:933-
943.
45. Lingappa, V. R., F. N. Katz, H. F. Lodish, and G. Blobel. 1978. Asignal sequence for
the insertion of a transmembrane glycoprotein: similarities to the signals of secretary
proteins in primary structure andfunction. J. Biol. Chem. 253:8667-8670.
46. Erickson, A. H., and G. Blobel. 1979. Early events in the biosynthesis ofthe lysosomal
enzyme,Cathepsin D. J. Biol. Chem. 254:11771-11774.
FERRO-NOVICK ET Al .
￿
Class B Yeast Secretary Mutants
￿
43